Bausch & Lomb (BLCO) Net Income (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Net Income came in at -$10.0 million in Q2 2026, up 82.76% on a YoY basis from -$5.5 million in Q2 2025, and up 85.71% quarter-over-quarter from -$70.0 million in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Net Income (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Net Income for 6 consecutive years, with -$10.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Income rose 82.76% year-over-year to -$10.0 million; the trailing twelve-month figure through Jun 2026 stood at -$163.0 million (up 38.02% YoY), and the FY2025 full-year result was -$352.0 million, down 15.41% from the prior year.
- Net Income grew to -$10.0 million in Q2 2026 per BLCO's latest filing, from -$70.0 million in the prior quarter.
- Across five years, Net Income topped out at $23.0 million in Q1 2022 and bottomed at -$211.0 million in Q1 2025.
- Historically, Net Income has averaged -$57.1 million across 5 years, with a median of -$51.0 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Net Income jumped 110.0% in 2024, then sank 2800.0% in 2025.
- Over 5 years, Net Income stood at -$15.0 million in 2022, then plunged by 240.0% to -$51.0 million in 2023, then jumped by 96.08% to -$2.0 million in 2024, then tumbled by 2800.0% to -$58.0 million in 2025, then jumped by 82.76% to -$10.0 million in 2026.
- According to Business Quant data, Net Income over the past three periods registered -$10.0 million, -$70.0 million, and -$58.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | -10.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.00 Mn |
| Mar 31, 2026 | -70.00 Mn |
| Dec 31, 2025 | -58.00 Mn |
| Sep 30, 2025 | -25.00 Mn |
| Jun 30, 2025 | -58.00 Mn |
| Mar 31, 2025 | -211.00 Mn |
| Dec 31, 2024 | -2.00 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | -148.00 Mn |
| Mar 31, 2024 | -163.00 Mn |
| Dec 31, 2023 | -51.00 Mn |
| Sep 30, 2023 | -80.00 Mn |
| Jun 30, 2023 | -29.00 Mn |
| Mar 31, 2023 | -88.00 Mn |
| Sep 30, 2022 | -15.00 Mn |
| Jun 30, 2022 | 7.00 Mn |
| Mar 31, 2022 | 23.00 Mn |
| Dec 31, 2021 | 54.00 Mn |
| Sep 30, 2021 | 63.00 Mn |
| Jun 30, 2021 | 46.00 Mn |